Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1953 1
1954 1
1958 1
1959 1
1961 4
1963 1
1967 1
1973 2
1976 1
1978 3
1979 1
1983 1
1984 1
1986 1
1987 1
1988 2
1989 3
1990 1
1991 2
1992 5
1993 1
1994 5
1995 6
1996 12
1997 9
1998 8
1999 8
2000 8
2001 8
2002 11
2003 19
2004 24
2005 47
2006 51
2007 52
2008 69
2009 70
2010 95
2011 127
2012 174
2013 190
2014 208
2015 190
2016 250
2017 294
2018 335
2019 336
2020 412
2021 532
2022 512
2023 484
2024 448
2025 20

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,434 results

Results by year

Filters applied: . Clear all
Page 1
SARS-CoV-2 variant biology: immune escape, transmission and fitness.
Carabelli AM, Peacock TP, Thorne LG, Harvey WT, Hughes J; COVID-19 Genomics UK Consortium; Peacock SJ, Barclay WS, de Silva TI, Towers GJ, Robertson DL. Carabelli AM, et al. Among authors: de silva ti. Nat Rev Microbiol. 2023 Mar;21(3):162-177. doi: 10.1038/s41579-022-00841-7. Epub 2023 Jan 18. Nat Rev Microbiol. 2023. PMID: 36653446 Free PMC article. Review.
Voyage sur la banquise : une perspective de traitement contre le cancer?
Da Silva T, Deiuri A, El-Tayar L, Gauthier M, Gimi N, Gordon J, Didier M, Laumonier T. Da Silva T, et al. Rev Med Suisse. 2023 Oct 4;19(844):1808-1809. doi: 10.53738/REVMED.2023.19.844.1808. Rev Med Suisse. 2023. PMID: 37791696 French. No abstract available.
Buschke-Lowenstein Tumor.
Silva TA, Col LSD, Beal PR, Resuto DP, Buonfiglio VB. Silva TA, et al. Urology. 2024 Nov;193:e82-e83. doi: 10.1016/j.urology.2024.08.056. Epub 2024 Aug 28. Urology. 2024. PMID: 39208943 No abstract available.
The APE1/REF-1 and the hallmarks of cancer.
Siqueira PB, de Sousa Rodrigues MM, de Amorim ÍSS, da Silva TG, da Silva Oliveira M, Rodrigues JA, de Souza da Fonseca A, Mencalha AL. Siqueira PB, et al. Among authors: da silva tg. Mol Biol Rep. 2024 Jan 2;51(1):47. doi: 10.1007/s11033-023-08946-9. Mol Biol Rep. 2024. PMID: 38165468 Review.
Endocrine Causes of Hypertension.
de Silva T, Cosentino G, Ganji S, Riera-Gonzalez A, Hsia DS. de Silva T, et al. Curr Hypertens Rep. 2020 Oct 20;22(11):97. doi: 10.1007/s11906-020-01108-3. Curr Hypertens Rep. 2020. PMID: 33079272 Review.
Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease.
Liew F, Efstathiou C, Fontanella S, Richardson M, Saunders R, Swieboda D, Sidhu JK, Ascough S, Moore SC, Mohamed N, Nunag J, King C, Leavy OC, Elneima O, McAuley HJC, Shikotra A, Singapuri A, Sereno M, Harris VC, Houchen-Wolloff L, Greening NJ, Lone NI, Thorpe M, Thompson AAR, Rowland-Jones SL, Docherty AB, Chalmers JD, Ho LP, Horsley A, Raman B, Poinasamy K, Marks M, Kon OM, Howard LS, Wootton DG, Quint JK, de Silva TI, Ho A, Chiu C, Harrison EM, Greenhalf W, Baillie JK, Semple MG, Turtle L, Evans RA, Wain LV, Brightling C, Thwaites RS, Openshaw PJM; PHOSP-COVID collaborative group; ISARIC investigators. Liew F, et al. Among authors: de silva ti. Nat Immunol. 2024 Apr;25(4):607-621. doi: 10.1038/s41590-024-01778-0. Epub 2024 Apr 8. Nat Immunol. 2024. PMID: 38589621 Free PMC article.
DELE1 promotes translation-associated homeostasis, growth, and survival in mitochondrial myopathy.
Lin HP, Petersen JD, Gilsrud AJ, Madruga A, D'Silva TM, Huang X, Shammas MK, Randolph NP, Li Y, Jones DR, Pacold ME, Narendra DP. Lin HP, et al. Among authors: d silva tm. bioRxiv [Preprint]. 2024 Feb 29:2024.02.29.582673. doi: 10.1101/2024.02.29.582673. bioRxiv. 2024. Update in: EMBO J. 2024 Nov;43(22):5548-5585. doi: 10.1038/s44318-024-00242-x PMID: 38529505 Free PMC article. Updated. Preprint.
An Overview of Renal Cell Carcinoma Hallmarks, Drug Resistance, and Adjuvant Therapies.
DA Silva Prade J, DE Souza RS, DA Silva D'Αvila CM, DA Silva TC, Livinalli IC, Bertoncelli ACZ, Saccol FK, DE Oliveira Mendes T, Wenning LG, DA Rosa Salles T, Rhoden CRB, Cadona FC. DA Silva Prade J, et al. Among authors: da silva tc. Cancer Diagn Progn. 2023 Nov 3;3(6):616-634. doi: 10.21873/cdp.10264. eCollection 2023 Nov-Dec. Cancer Diagn Progn. 2023. PMID: 37927802 Free PMC article. Review.
Pre-clinical development of AP4B1 gene replacement therapy for hereditary spastic paraplegia type 47.
Wiseman JP, Scarrott JM, Alves-Cruzeiro J, Saffari A, Böger C, Karyka E, Dawes E, Davies AK, Marchi PM, Graves E, Fernandes F, Yang ZL, Coldicott I, Hirst J, Webster CP, Highley JR, Hackett N, Angyal A, Silva T, Higginbottom A, Shaw PJ, Ferraiuolo L, Ebrahimi-Fakhari D, Azzouz M. Wiseman JP, et al. Among authors: silva t. EMBO Mol Med. 2024 Nov;16(11):2882-2917. doi: 10.1038/s44321-024-00148-5. Epub 2024 Oct 2. EMBO Mol Med. 2024. PMID: 39358605 Free PMC article.
Siglec 15 as a biomarker or a druggable molecule for non-small cell lung cancer.
Moreira RS, da Silva MM, de Melo Vasconcelos CF, da Silva TD, Cordeiro GG, Mattos-Jr LAR, da Rocha Pitta MG, de Melo Rêgo MJB, Pereira MC. Moreira RS, et al. Among authors: da silva td. J Cancer Res Clin Oncol. 2023 Dec;149(19):17651-17661. doi: 10.1007/s00432-023-05437-z. Epub 2023 Oct 16. J Cancer Res Clin Oncol. 2023. PMID: 37843557 Review.
4,434 results